275 related articles for article (PubMed ID: 16303137)
1. Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy.
Apetri MM; Maiti NC; Zagorski MG; Carey PR; Anderson VE
J Mol Biol; 2006 Jan; 355(1):63-71. PubMed ID: 16303137
[TBL] [Abstract][Full Text] [Related]
2. A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein.
Du HN; Tang L; Luo XY; Li HT; Hu J; Zhou JW; Hu HY
Biochemistry; 2003 Jul; 42(29):8870-8. PubMed ID: 12873148
[TBL] [Abstract][Full Text] [Related]
3. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins.
Schnack C; Danzer KM; Hengerer B; Gillardon F
Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383
[TBL] [Abstract][Full Text] [Related]
4. Rapid self-assembly of alpha-synuclein observed by in situ atomic force microscopy.
Hoyer W; Cherny D; Subramaniam V; Jovin TM
J Mol Biol; 2004 Jun; 340(1):127-39. PubMed ID: 15184027
[TBL] [Abstract][Full Text] [Related]
5. The lipid peroxidation metabolite 4-oxo-2-nonenal cross-links alpha-synuclein causing rapid formation of stable oligomers.
Näsström T; Wahlberg T; Karlsson M; Nikolajeff F; Lannfelt L; Ingelsson M; Bergström J
Biochem Biophys Res Commun; 2009 Jan; 378(4):872-6. PubMed ID: 19070597
[TBL] [Abstract][Full Text] [Related]
6. Assembly of alpha-synuclein fibrils in nanoscale studied by peptide truncation and AFM.
Zhang F; Lin XJ; Ji LN; Du HN; Tang L; He JH; Hu J; Hu HY
Biochem Biophys Res Commun; 2008 Apr; 368(2):388-94. PubMed ID: 18230346
[TBL] [Abstract][Full Text] [Related]
7. The aggregation and fibrillation of alpha-synuclein.
Fink AL
Acc Chem Res; 2006 Sep; 39(9):628-34. PubMed ID: 16981679
[TBL] [Abstract][Full Text] [Related]
8. Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein.
Heise H; Celej MS; Becker S; Riedel D; Pelah A; Kumar A; Jovin TM; Baldus M
J Mol Biol; 2008 Jul; 380(3):444-50. PubMed ID: 18539297
[TBL] [Abstract][Full Text] [Related]
9. Protein interactions and misfolding analyzed by AFM force spectroscopy.
McAllister C; Karymov MA; Kawano Y; Lushnikov AY; Mikheikin A; Uversky VN; Lyubchenko YL
J Mol Biol; 2005 Dec; 354(5):1028-42. PubMed ID: 16290901
[TBL] [Abstract][Full Text] [Related]
10. Structural properties of pore-forming oligomers of alpha-synuclein.
Kim HY; Cho MK; Kumar A; Maier E; Siebenhaar C; Becker S; Fernandez CO; Lashuel HA; Benz R; Lange A; Zweckstetter M
J Am Chem Soc; 2009 Dec; 131(47):17482-9. PubMed ID: 19888725
[TBL] [Abstract][Full Text] [Related]
11. Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease.
Kumar S; Sarkar A; Sundar D
Biochem Biophys Res Commun; 2009 Sep; 387(2):305-9. PubMed ID: 19580781
[TBL] [Abstract][Full Text] [Related]
12. Role of different regions of alpha-synuclein in the assembly of fibrils.
Qin Z; Hu D; Han S; Hong DP; Fink AL
Biochemistry; 2007 Nov; 46(46):13322-30. PubMed ID: 17963364
[TBL] [Abstract][Full Text] [Related]
13. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
Meredith SC
Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
[TBL] [Abstract][Full Text] [Related]
14. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation.
Leong SL; Pham CL; Galatis D; Fodero-Tavoletti MT; Perez K; Hill AF; Masters CL; Ali FE; Barnham KJ; Cappai R
Free Radic Biol Med; 2009 May; 46(10):1328-37. PubMed ID: 19248830
[TBL] [Abstract][Full Text] [Related]
15. Effects of nitration on the structure and aggregation of alpha-synuclein.
Uversky VN; Yamin G; Munishkina LA; Karymov MA; Millett IS; Doniach S; Lyubchenko YL; Fink AL
Brain Res Mol Brain Res; 2005 Mar; 134(1):84-102. PubMed ID: 15790533
[TBL] [Abstract][Full Text] [Related]
16. Seed-dependent accelerated fibrillation of alpha-synuclein induced by periodic ultrasonication treatment.
Kim HJ; Chatani E; Goto Y; Paik SR
J Microbiol Biotechnol; 2007 Dec; 17(12):2027-32. PubMed ID: 18167451
[TBL] [Abstract][Full Text] [Related]
17. Isolating recombinant antibodies against specific protein morphologies using atomic force microscopy and phage display technologies.
Barkhordarian H; Emadi S; Schulz P; Sierks MR
Protein Eng Des Sel; 2006 Nov; 19(11):497-502. PubMed ID: 16984950
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.
Azeredo da Silveira S; Schneider BL; Cifuentes-Diaz C; Sage D; Abbas-Terki T; Iwatsubo T; Unser M; Aebischer P
Hum Mol Genet; 2009 Mar; 18(5):872-87. PubMed ID: 19074459
[TBL] [Abstract][Full Text] [Related]
19. Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure.
Celej MS; Sarroukh R; Goormaghtigh E; Fidelio GD; Ruysschaert JM; Raussens V
Biochem J; 2012 May; 443(3):719-26. PubMed ID: 22316405
[TBL] [Abstract][Full Text] [Related]
20. Association of alpha-synuclein and mutants with lipid membranes: spin-label ESR and polarized IR.
Ramakrishnan M; Jensen PH; Marsh D
Biochemistry; 2006 Mar; 45(10):3386-95. PubMed ID: 16519533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
